Coeptis Therapeutics
Why Robinhood?
You can watch COEP and buy or sell other stocks, ETFs, and their options commission-free!About COEP
Coeptis Therapeutics Holdings, Inc. is a biopharmaceutical company, which engages in developing innovative cell therapy platforms for cancer that can disrupt conventional treatment paradigms and improve patient outcomes. The firm's products include CD38-GEAR-NK, CD38-Diagnostic and GEAR-NK Product.
COEP Key Statistics
Stock Snapshot
As of today, Coeptis Therapeutics(COEP) shares are valued at $15.20. The company's market cap stands at 632.64M, with a P/E ratio of -9.76.
On 2026-06-10, Coeptis Therapeutics(COEP) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for Coeptis Therapeutics(COEP) stock has reached 0, versus its average volume of 23.47M.
The stock's 52-week range extends from a low of $0.13 to a high of $0.79.
The stock's 52-week range extends from a low of $0.13 to a high of $0.79.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.